UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Journal of clinical oncology, 2019-03, Vol.37 (7), p.559-569

2019

Volltextzugriff (PDF)

A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes

PloS one, 2014-07, Vol.9 (7), p.e103512-e103512

2014

Volltextzugriff (PDF)

Strategies for the discovery and development of therapies for metastatic breast cancer

Nature reviews. Drug discovery, 2012-06, Vol.11 (6), p.479-497

2012

Volltextzugriff (PDF)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.122-137

2018

Volltextzugriff (PDF)

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"

PLoS medicine, 2016-12, Vol.13 (12), p.e1002204-e1002204

2016

Volltextzugriff (PDF)

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

The New England journal of medicine, 2015-03, Vol.372 (10), p.923-932

2015

Volltextzugriff (PDF)

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Journal of clinical oncology, 2017-09, Vol.35 (27), p.3113-3122

2017

Volltextzugriff (PDF)

Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Breast cancer research : BCR, 2020-08, Vol.22 (1), p.91-91, Article 91

2020

Volltextzugriff (PDF)

Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials

Breast (Edinburgh), 2022-08, Vol.64, p.56-62

2022

Volltextzugriff (PDF)

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4498-4504

2011

Volltextzugriff (PDF)

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Breast cancer research : BCR, 2022-07, Vol.24 (1), p.1-50, Article 50

2022

Volltextzugriff (PDF)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

NPJ breast cancer, 2022-01, Vol.8 (1), p.3-3, Article 3

2022

Volltextzugriff (PDF)

Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer

Trials, 2020-03, Vol.21 (1), p.295-295, Article 295

2020

Volltextzugriff (PDF)

Role of Ovarian Suppression in Early Premenopausal Breast Cancer

Hematology/oncology clinics of North America, 2023-02, Vol.37 (1), p.79-88

Francis, Prudence A.

2023

Volltextzugriff (PDF)

PEG‐GCSF‐induced aortitis in a patient with breast cancer: distinguishing between infective and immune‐mediated aortitis

Medical journal of Australia, 2024-04, Vol.220 (6), p.307-309

2024

Volltextzugriff (PDF)

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1293-1303

2020

Volltextzugriff (PDF)

Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration

Breast (Edinburgh), 2019-11, Vol.48 Suppl 1, p.S85-S88

Francis, Prudence A

2019

Volltextzugriff (PDF)

Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index

Journal of clinical oncology, 2020-09, Vol.38 (25), p.2883-2891

2020

Volltextzugriff (PDF)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

The lancet oncology, 2022-03, Vol.23 (3), p.382-392

2022

Volltextzugriff (PDF)

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"

PLoS medicine, 2017-04, Vol.14 (4), p.e1002302-e1002302

2017

Volltextzugriff (PDF)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

NPJ breast cancer, 2021-05, Vol.7 (1), p.67-67, Article 67

2021

Volltextzugriff (PDF)

Light enhanced cognitive behavioral therapy for insomnia and fatigue during chemotherapy for breast cancer: a randomized controlled trial

Sleep (New York, N.Y.), 2022-03, Vol.45 (3), p.1

2022

Volltextzugriff (PDF)

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials

Journal of clinical oncology, 2016-07, Vol.34 (19), p.2221-2231

2016

Volltextzugriff (PDF)

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2015-01, Vol.372 (5), p.436-446

2015

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Englisch
(185)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(100)
Humans
(91)
Female
(83)
Oncology
(68)
Breast Cancer
(55)
Breast Neoplasms - Drug Therapy
(54)
Adult
(44)
Middle Aged
(43)
Chemotherapy, Adjuvant
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Aged
(28)
Chemotherapy
(28)
Breast Neoplasms - Pathology
(24)
Premenopause
(22)
Disease-Free Survival
(21)
Cancer Research
(18)
Biological And Medical Sciences
(17)
Clinical Trials
(17)
Medical Sciences
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes

Strategies for the discovery and development of therapies for metastatic breast cancer

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer

Role of Ovarian Suppression in Early Premenopausal Breast Cancer

PEG‐GCSF‐induced aortitis in a patient with breast cancer: distinguishing between infective and immune‐mediated aortitis

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration

Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

Light enhanced cognitive behavioral therapy for insomnia and fatigue during chemotherapy for breast cancer: a randomized controlled trial

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Suchergebnisse filtern